LBA14 Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 5-year outcomes
作者
J.P. Crown,Daniil Stroyakovskiy,Denise Aysel Yardley,Chiun‐Sheng Huang,Peter Andreas Fasching,Aditya Bardia,S. Chia,Seock‐Ah Im,M. Martin,Baichuan Xu,Carlos H. Barrios,Michael Untch,R.L. Moroose,S.A. Hurvitz,Gabriel N. Hortobágyi,D. Slamon,Frances M. Visco,Gonzalo Spera,Zhouxiao Li,Sherene Loi
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2025-09-01卷期号:36: S1559-S1559被引量:3